Postmarketing adverse drug reactions A duty to report?

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Physicians play an important role in recognizing and reporting suspected adverse drug reactions (ADRs) to the Food and Drug Administration (FDA). Physicians can report suspected ADRs directly to the FDA via its MedWatch program, by contacting the manufacturer of the drug, and by publishing case reports. While this takes time, physicians have an ethical obligation to participate in recognizing and reporting ADR.

Original languageEnglish (US)
Pages (from-to)288-294
Number of pages7
JournalNeurology: Clinical Practice
Volume3
Issue number4
DOIs
StatePublished - Aug 1 2013

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Postmarketing adverse drug reactions A duty to report?'. Together they form a unique fingerprint.

  • Cite this